Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
102
Views
23
CrossRef citations to date
0
Altmetric
Original Research

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma

Shuo Li1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Huaxiang Xu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Wenquan Wang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Heli Gao1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Hao Li1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Shirong Zhang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Jinzhi Xu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Wuhu Zhang1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Shuaishuai Xu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Tianjiao Li1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Quanxing Ni1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Xianjun Yu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
,
Chuntao Wu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Liang Liu1 Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, People’s Republic of China;2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People’s Republic of China;3 Shanghai Pancreatic Cancer Institute, Shanghai 200032, People’s Republic of China;4 Pancreatic Cancer Institute, Fudan University, Shanghai 200032, People’s Republic of China
 show all
Pages 3327-3337 | Published online: 17 Apr 2019

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xian-Wen Liang, Bing Liu, Hai-Jing Yu, Jia-Cheng Chen, Zhi Cao, Sheng-Zhong Wang & Jin-Cai Wu. (2023) Prognostic Significance of the Systemic Inflammation Response Index in Gastrointestinal Malignancy Patients: A pooled Analysis of 10,091 Participants. Future Oncology 19:29, pages 1991-2002.
Read now
Konstantinos Kamposioras, George Papaxoinis, Mohamed Dawood, Jordan Appleyard, Fiona Collinson, Angela Lamarca, Usman Ahmad, Richard A. Hubner, Francesca Wright, Rille Pihlak, Iva Damyanova, Bilal Razzaq, Juan W. Valle, Mairéad G. McNamara & Alan Anthoney. (2022) Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy. Acta Oncologica 61:5, pages 583-590.
Read now

Articles from other publishers (21)

Vilma Pacheco-Barcia, Sara Custodio-Cabello, Fatima Carrasco-Valero, Magda Palka-Kotlowska, Axel Mariño-Mendez, Alberto Carmona-Bayonas, Javier Gallego, A J Muñoz Martín, Paula Jimenez-Fonseca & Luis Cabezon-Gutierrez. (2024) Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial. World Journal of Gastrointestinal Oncology 16:2, pages 386-397.
Crossref
Tianyi Fang, Xin Yin, Yufei Wang, Lei Zhang, Shuo Yang, Xinju Jiang & Yingwei Xue. (2024) Clinical significance of systemic inflammation response index and platelet–lymphocyte ratio in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer. Heliyon 10:4, pages e26176.
Crossref
Yuze Zhai, Benjun Wang, Weiwei Han, Bianfang Yu, Jichen Ci & Fan An. (2024) Correlation between systemic inflammatory response index and thyroid function: 2009-2012 NHANES results. Frontiers in Endocrinology 14.
Crossref
Yong-Wei Huang, Ye Zhang, Cui Feng, Yin-Hua An, Zong-Ping Li & Xiao-Shuang Yin. (2023) Systemic inflammation response index as a clinical outcome evaluating tool and prognostic indicator for hospitalized stroke patients: a systematic review and meta-analysis. European Journal of Medical Research 28:1.
Crossref
Stephen Murata, Nausheen Baig, Kyle Decker & Angelos Halaris. (2023) Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients. Journal of Personalized Medicine 13:9, pages 1408.
Crossref
Catalina Filip, Roxana Covali, Demetra Socolov, Mona Akad, Alexandru Carauleanu, Ingrid Andrada Vasilache, Ioana Sadyie Scripcariu, Ioana PavaleanuGabriela Dumachita-SarguTudor ButureanuLucian Vasile Boiculese, Alina Melinte & Razvan Socolov. (2023) The Influence of Climate on Critically Ill Pregnant COVID-19 Patients, as Revealed by the Inflammation Indexes, in Spring versus Autumn 2021 Infection. Balneo and PRM Research Journal:Vol.14, no.3, pages 571.
Crossref
Li Wang, Xianfei Qin, Yu Zhang, Shouyu Xue & Xicheng Song. (2023) The prognostic predictive value of systemic immune index and systemic inflammatory response index in nasopharyngeal carcinoma: A systematic review and meta-analysis. Frontiers in Oncology 13.
Crossref
Shuqi Mao, Xi Yu, Jihan Sun, Yong Yang, Yuying Shan, Jiannan Sun, Joseph Mugaanyi, Rui Fan, Shengdong Wu & Caide Lu. (2022) Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection. BMC Cancer 22:1.
Crossref
Lili Xiong, Cuihua Fan, Jia Song, Yu Wan, Xiuqin Lin, Zujian Su, Jianmin Qiu, WeiLiang Wu, Zhini He, Yongning Wu & Xingfen Yang. (2022) Associations of long-term cadmium exposure with peripheral white blood cell subtype counts and indices in residents of cadmium-polluted areas. Chemosphere 308, pages 135946.
Crossref
Sara Dâmaso, Rita Paiva, Inês Pinho, Miguel Esperança-Martins, Raquel Lopes Brás, Cecília Melo Alvim, António Quintela, Ana Lúcia Costa & Luís Costa. (2022) Systemic inflammatory response index is a prognostic biomarker in unresectable pancreatic adenocarcinoma and identifies patients for more intensive treatment. memo - Magazine of European Medical Oncology 15:3, pages 246-252.
Crossref
Mario Schietroma, Lucia Romano, Daniela Schiavi, Beatrice Pessia, Antonella Mattei, Fabiana Fiasca, Francesco Carlei & Antonio Giuliani. (2022) Systemic inflammation response index (SIRI) as predictor of anastomotic leakage after total gastrectomy for gastric cancer. Surgical Oncology 43, pages 101791.
Crossref
Haoda Chen, Fanlu Li, Siyi Zou, Junjie Xie, Jun Zhang, Xiaxing Deng, Hao Chen & Baiyong Shen. (2021) Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection. World Journal of Surgical Oncology 19:1.
Crossref
Yanan Zhang, Zeyang Chen, Feng Jin, Dong Guo, Qingqing Chen, Zhengcao Liu, Shengjun Ji & Guanqi Gao. (2021) The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy. Mediators of Inflammation 2021, pages 1-10.
Crossref
Qian Zhou, Si Su, Wen You, Tao Wang, Tong Ren & Lan Zhu. (2021) Systemic Inflammation Response Index as a Prognostic Marker in Cancer Patients: A Systematic Review and Meta-Analysis of 38 Cohorts. Dose-Response 19:4, pages 155932582110647.
Crossref
Buket ALTUN ÖZDEMİR, Güzelali ÖZDEMİR, Niyazi YAŞAR, Olgun BİNGÖL, Hakan ATAŞ & Bülent ÇOMÇALI. (2020) Are the Factors Affecting Mortality in Elderly Polytrauma Patients Different from Those Affecting Younger Patients?Yaşlı Politravma Hastalarında Mortaliteyi Etkileyen Faktörler Genç Hastalardan Farklı mıdır?. SDÜ Tıp Fakültesi Dergisi 27:4, pages 511-517.
Crossref
Cong Jiang, Yubo Lu, Shiyuan Zhang & Yuanxi Huang. (2020) Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. BioMed Research International 2020, pages 1-10.
Crossref
Lishuang Wei, Hailun XiePing Yan. (2020) Prognostic value of the systemic inflammation response index in human malignancy. Medicine 99:50, pages e23486.
Crossref
Yi Zhang, Fangteng Liu & Yang Wang. (2020) Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies. Disease Markers 2020, pages 1-10.
Crossref
Li Chen, Xiangyi Kong, Zhongzhao Wang, Xiangyu Wang, Yi Fang & Jing Wang. (2020) Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy. Journal of Cellular and Molecular Medicine 24:5, pages 2993-3021.
Crossref
Nicole Brighi, Alberto Farolfi, Vincenza Conteduca, Giorgia Gurioli, Stefania Gargiulo, Valentina Gallà, Giuseppe Schepisi, Cristian Lolli, Chiara Casadei & Ugo De Giorgi. (2019) The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment. Cancers 11:12, pages 1935.
Crossref
Chaobin He, Xin Huang, Yu Zhang, Zhiyuan Cai, Xiaojun Lin & Shengping Li. (2019) A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection. Frontiers in Oncology 9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.